- Investing Ideas
- /
- Global High Growth Potential Companies
Global High Growth Potential Companies
UPDATED May 18, 2024
Companies with a Future performance score of at least 3, ordered by Future performance score.
8,600 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
A067310 | ₩26,450.00 | -0.8% | 49.6% | ₩1.3t | ₩36,000.00 | PS1.3x | E67.2% | 0.2% | Semiconductors | ||
301358 | CN¥40.04 | 0.4% | -7.4% | CN¥30.3b | n/a | PE20.8x | E30.3% | 1.0% | Capital Goods | ||
A247540 | ₩212,500.00 | -2.3% | -6.2% | ₩20.8t | ₩228,880.00 | PS3x | E38.7% | 0% | Capital Goods | ||
688793 | CN¥32.39 | 0.1% | -18.9% | CN¥2.7b | CN¥37.52 | PS2x | E67.5% | 0% | Household | ||
5038 | JP¥1,265.00 | -13.2% | -47.1% | JP¥18.9b | n/a | PE30.6x | E26.5% | n/a | Healthcare | ||
688700 | CN¥39.58 | 1.3% | -37.0% | CN¥9.1b | CN¥47.47 | PE68.9x | E44.8% | 0.6% | Capital Goods | ||
OSE | €7.41 | 9.8% | 96.0% | €160.8m | €7.15 | PS72.2x | E92.9% | n/a | Pharmaceuticals & Biotech | ||
A178320 | ₩25,200.00 | -4.2% | 54.6% | ₩1.2t | ₩34,500.00 | PE112.4x | E48.1% | 0% | Tech | ||
ATAKP | ₺46.54 | 4.3% | n/a | ₺6.5b | ₺67.66 | PE21.8x | E72.8% | n/a | Food, Beverage & Tobacco | ||
7096 | JP¥1,821.00 | -4.7% | -21.4% | JP¥18.7b | n/a | PE60.2x | E33.4% | n/a | Healthcare | ||
CALTX | kr117.20 | 5.8% | 13.8% | kr6.3b | kr208.00 | PS5.2x | E49.9% | n/a | Pharmaceuticals & Biotech | ||
NVG | zł2.09 | -2.3% | 20.5% | zł73.2m | zł3.71 | PE14.5x | E29.0% | n/a | Diversified Financials | ||
KEBNI B | kr1.43 | -2.7% | 37.1% | kr386.7m | kr2.20 | PS4.2x | E90.4% | n/a | Tech | ||
NEWBRY | kr3.10 | -5.2% | -44.4% | kr75.2m | kr8.00 | PS3.3x | E112.9% | n/a | Pharmaceuticals & Biotech | ||
ADOC | €9.55 | 10.7% | 167.5% | €137.5m | €9.70 | PS22.7x | E104.5% | n/a | Pharmaceuticals & Biotech | ||
GWIND | ₺28.98 | -0.1% | 95.0% | ₺15.6b | ₺39.79 | PE25.1x | E60.9% | 1.6% | Utilities | ||
A335890 | ₩10,380.00 | -7.8% | 60.2% | ₩599.4b | ₩12,500.00 | PE41.9x | E29.3% | 0.2% | Healthcare | ||
TGTX | US$16.48 | -0.8% | -45.0% | US$2.4b | US$31.50 | PE57.3x | E48.0% | n/a | Pharmaceuticals & Biotech | ||
MBTN | CHF0.01 | -8.3% | -98.2% | CHF237.3m | n/a | PS1.8x | E83.0% | n/a | Semiconductors | ||
FDE | €37.15 | 3.3% | -2.1% | €194.3m | €64.07 | PE24.7x | E37.6% | n/a | Energy | ||
AGP | €8.15 | -2.0% | 144.7% | €141.1m | €12.75 | PE28.7x | E22.8% | n/a | Capital Goods | ||
AXSM | US$76.54 | 5.6% | 1.1% | US$3.6b | US$123.56 | PS14.5x | E65.1% | n/a | Pharmaceuticals & Biotech | ||
SFPTECH | RM0.84 | 12.7% | 3.9% | RM2.0b | n/a | PE53.2x | E25.3% | 0.5% | Capital Goods | ||
CYC | AU$1.60 | -7.0% | -25.2% | AU$150.7m | AU$4.35 | PS5.6x | E89.2% | 0% | Healthcare |